A new preclinical model offers a unique platform for studying the Parkinson's disease process and suggests a relatively easy method for detecting the disease in people. A new preclinical model offers ...
For decades, medical understanding of Parkinson’s disease focused exclusively on the brain, specifically the death of dopamine-producing neurons that control movement. This narrow view shaped ...
Beta-amyloid plaques are considered a hallmark of Alzheimer’s disease, but they’re not the sole cause of the disease and its symptoms. Alzheimer’s is a complicated disease that experts are still ...
When David Fajgenbaum and his colleagues launched the drug repurposing non-profit Every Cure, they chose a path that ...
Hosted on MSN
Sugars on immune cells, not just blood vessel walls, may regulate the inflammatory disease process
New research has updated the understanding of how sugars, known as glycans, help immune cells move into the skin in the inflammatory disease, psoriasis. Subscribe to our newsletter for the latest ...
Esther Landhuis is a journalist in the San Francisco Bay Area. She holds a Ph.D. in immunology and covers biomedicine in all dimensions, from bench discoveries to biotech to health care. Alzheimer’s ...
Drug Farm today announced that the U.S. Food and Drug Administration (U.S. Food and Drug Administration, FDA) has accepted DF-003, the company's investigational therapy for ROSAH syndrome, into the ...
People affected by Huntington’s disease could at last benefit from the first treatment to slow the fatal neurodegenerative condition. Scientists from University College London (UCL) found patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results